IP Library Granted Patent US 8,747,829
Granted Patent B2
US 8,747,829 · App. 13/028,766 · Granted Jun 10, 2014

Presbyopia treatment by lens alteration of disulfide bonds and reduction

Inventors: Jonathan S. Till (Roanoke, VA); Ronald D. Blum (Roanoke, VA)
Assignee: Encore Health, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,747,829
App. No.
13/028,766
Granted
Jun 10, 2014
Kind
B2
Abstract

This invention effects a change in the accommodation of the human lens affected by presbyopia through the use of various reducing agents that change accommodative abilities of the human lens, and/or by applying energy to affect a change in the accommodative abilities of the human lens. This invention both prevents the onset of presbyopia as well as treats it. By breaking and/or preventing the formation of bonds that adhere lens fibers together causing hardening of the lens, the present invention increases the elasticity and distensibility of the lens and/or lens capsule.

Claims (18)

1. A method for increasing accommodative amplitude of a lens of an eye comprising administering to the eye a biochemical energy source to facilitate breaking of lenticular disulfide bonds and a reducing agent to reduce the likelihood of reformation of lenticular disulfide bonds.

2. The method of claim 1 , wherein the biochemical energy source comprises glucose-6-phosphate.

3. The method of claim 1 , further comprising administering a catalyst.

4. The method of claim 3 , wherein the catalyst comprises a reductase.

5. The method of claim 3 , wherein the catalyst comprises an aldoreductase.

6. The method of claim 3 , wherein the catalyst comprises a glyoxylase.

7. The method of claim 3 , wherein the catalyst comprises a glutathione S-transferase.

8. The method of claim 3 , wherein the catalyst comprises a thiol reductase.

9. The method of claim 3 , wherein the catalyst comprises a tyrosine reductase.

10. The method of claim 3 , wherein the catalyst comprises a hexokinase.

11. The method of claim 1 , wherein the reducing agent is glutathione, ascorbic acid, a thiol derivative, vitamin E, tetraethylthiuram disulfyl, ophthalmic acid, inositol, or a beta-carboline.

12. The method of claim 1 , further comprising administering a methylating agent selected from the group consisting of methyl-methane thiosulfonate, methyl glutathione, S-methyl glutathione, S-transferase, wherein the reducing agent is capable of reducing the disulfide bonds into sulfhydryl groups; and wherein the methylating agent is capable of methylating the sulfhydryl groups.

13. The method of claim 12 , wherein the methylating agent comprises methyl-methane thiosulfonate.

14. The method of claim 12 , wherein the methylating agent comprises methyl glutathione.

15. The method of claim 12 , wherein the methylating agent comprises 5-methyl glutathione.

16. The method of claim 12 , wherein the methylating agent comprises S-transferase.

17. The method of claim 1 , wherein the lens is a lens of a human eye.

18. The method of claim 17 , further comprising applying an external energy source in a form of electromagnetic radiation, sound, or heat to the lens.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2013
From: TILL, JONATHAN S.
To: REFOCUS, LLC
Reel/Frame 031090/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2013
From: TILL, JONATHAN S.; BLUM, RONALD D.
To: NEWLENS, LLC
Reel/Frame 031090/0609 →
CHANGE OF NAME Recorded Aug 27, 2013
From: REFOCUS, LLC
To: NEWLENS, LLC
Reel/Frame 031094/0753 →
CHANGE OF NAME Recorded Aug 27, 2013
From: NEWLENS, LLC
To: ENCORE HEALTH LLC
Reel/Frame 031094/0755 →
Continuity (6)
Division 11010436 · Dec 14, 2004
Continuation 10050879 · Jan 18, 2002
Continuation In Part 09930287 · Aug 16, 2001
Provisional Application 60262423 · Jan 19, 2001
Provisional Application 60225659 · Aug 16, 2000
Related Publication 20110135622A1 · Jun 9, 2011